Study finds no association between maternal SARS-CoV-2 infection and infant neurodevelopment Coronavirus COVID neurodevelopment infanthealth telehealthassessment observationalstudy publichealth maternalhealth asymptomatic JAMANetworkOpen
By Dr. Chinta SidharthanApr 13 2023Reviewed by Lily Ramsey, LLM In a recent study published in the journal JAMA Network Open, researchers assessed whether exposure to mild or asymptomatic maternal severe acute respiratory syndrome coronavirus 2 infections during the pregnancy impacted the neurodevelopment of the infant.
While there have been very few cases of vertical transmission of SARS-CoV-2 from mother to fetus, maternal immune activation and other such mechanisms can alter the infant's neurodevelopment. All delivering patients enrolled in the two studies were tested for SARS-CoV-2 through either a polymerase chain reaction test of nasopharyngeal swabs or a serological test for antibodies against the virus.
The assessments were conducted through interviews with the parents or caregivers, direct behavioral observations, and direct assessments by the research assistants.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Study suggests detecting new SARS-CoV-2 variants in inbound travelers more effective than community surveillanceStudy suggests detecting new SARS-CoV-2 variants in inbound travelers more effective than community surveillance Coronavirus Disease COVID SARSCoV2 medrxivpreprint
Read more »
SARS-CoV-2 infection among infants born to maternal COVID-19 cases during Omicron variant predominanceSARS-CoV-2 infection among infants born to maternal COVID-19 cases during Omicron variant predominance JPediatr CDCgov maternalcovid covid COVID19 SARSCoV2 omicron variant spread infant childhealth
Read more »
Mucosal vaccines for SARS-CoV-2: scientific gaps and opportunities—workshop report - npj VaccinesOn November 7th and 8th, 2022, The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), The Coalition for Epidemic Preparedness Innovation (CEPI), The Bill & Melinda Gates Foundation (BMGF), The Biomedical Advanced Research and Development Authority (BARDA), and the Wellcome Trust hosted a virtual workshop entitled “Mucosal Vaccines for SARS-CoV-2: Scientific Gaps and Opportunities.” During the workshop, researchers and vaccine developers from around the world discussed the potential of mucosal vaccines to block SARS-CoV-2 transmission and reviewed the status of SARS-CoV-2 mucosal vaccine research. Here, we summarize key challenges and opportunities in basic, translational, and clinical research that were highlighted during the meeting. We also provide recommendations to advance the field and accelerate the development of mucosal vaccines for SARS-CoV-2.
Read more »
Frontiers | DNA immunization with in silico predicted T-cell epitopes protects against lethal SARS-CoV-2 infection in K18-hACE2 miceThe global SARS-CoV-2 pandemic caused significant global disruption, both socially and economically, despite highly effective vaccines being developed at an unprecedented speed. As the first licensed vaccines only target single B-cell antigens, antigenic drift could lead to loss of efficacy against emerging SARS-CoV-2 variants. Improvement of the B-cell vaccines by including multiple T-cell epitopes could potentially solve this challenge. Here we show that in silico predicted MHC class I/II ligands induced robust T-cell responses and protected against severe disease in genetically modified K18-hACE2/BL6 mice susceptible to SARS-CoV-2 infection.
Read more »
The virological characteristics of XBB.1.16The virological characteristics of XBB.1.16 Coronavirus Disease COVID Omicron SARSCoV2 XBB116 biorxivpreprint KobeU_Global UTokyo_News_en CharlesUniPRG
Read more »
Researchers map genetic signature of precursor to liver cancerResearchers at Curtin University have identified the genetic signature of pre-malignant liver cells, offering potentially significant implications for the almost 3,000 Australians diagnosed with the deadly cancer each year.
Read more »